Post-earnings recap
Reported
Wed, Oct 30, 2024
EPS actual
$5.58
EPS est.
$5.11
EPS surprise
+9.22%
1-day move
-0.15%
Amgen's earnings report showed a positive surprise in EPS, indicating better-than-expected profitability. However, the stock dipped slightly by 0.15%, suggesting that investors may have been looking for more comprehensive revenue details or guidance. The lack of revenue data and future guidance may have contributed to the muted stock reaction.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $5.58 | N/A | +9.22% |
| Revenue | N/A | N/A | N/A |
Overall, management expressed confidence in the company's strategic direction despite not providing specific guidance. They noted positive trends in product demand.
Management highlighted strong performance in key therapeutic areas.
They emphasized ongoing commitment to innovation and pipeline development.
Est. EPS
—
Est. Rev
—
Impl. Move
—